5Sobh MA, el-Tantawy AE, Said E, Atta MG, Refaie A, Nagati M, et al. Effect of treatment of anaemia with erythropoietin on neuromuscular function in patients on long-term haemodialysis [J]. Scand J Urol Nephrol, 1992, 26(3) : 65-69.
6Spandou E, Papoutsopoulou S, Soubasi V, Karkavelas G, Sime- onidou C, Kremenopoulos G, et al. Hypoxia-ischemia affects erythropoietin and erythropoietin receptor expression pattern in the neonatal rat brain[J]. Brain Res, 2004, 1021(2) : 167-172.
7Konstantinopoulos PA, Karamouzis MV, Papavassiliou AG. Selec- tive modulation of the erythropoietic and tissue-protective effects of erythropoietin : time to reach the full therapeutic potential of eryth- ropoietin[ J]. Biochim Biophys Acta, 2007, 1776( 1 ) : 1-9.
8Tao WY, Wen F, Zhang H, Liua G. The signal transduction me- diated by erythropoietin and proinflammatory cytokines in the JAK/STAT pathway in the children with cerebral palsy[ J ]. Brain Dev, 2009, 31(3) : 200-207.
9Semenza GL, Wang GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation [ J ]. Mol Cell Biol, 1992, 12(12) : 5447-5454.
10Martinez-Estrada OM, Rodriguez-Millan E, Gonzalez-De Vicente E, Reina M. Erythropoietin protects the in vitro blood-brain batTi- er against VEGF-induced permeability [ J ]. Eur J Neurosci, 2003, 18(9) : 2538-2544.
